BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,245 | -99.8% | 1,262,000 | +146.5% | 0.00% | – |
| Q2 2022 | $507,000 | -83.2% | 512,000 | -82.9% | 0.00% | -100.0% |
| Q1 2022 | $3,021,000 | +154.9% | 3,000,000 | +164.6% | 0.00% | +100.0% |
| Q3 2020 | $1,185,000 | +558.3% | 1,134,000 | +671.4% | 0.00% | – |
| Q2 2020 | $180,000 | -96.4% | 147,000 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $4,946,000 | +19.9% | 4,665,000 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $4,126,000 | +410.6% | 4,187,000 | +430.0% | 0.00% | +200.0% |
| Q1 2019 | $808,000 | -90.2% | 790,000 | -90.3% | 0.00% | -85.7% |
| Q2 2018 | $8,254,000 | +1746.5% | 8,171,000 | +1616.6% | 0.01% | – |
| Q1 2018 | $447,000 | -93.3% | 476,000 | -92.9% | 0.00% | -100.0% |
| Q4 2017 | $6,664,000 | +82.6% | 6,689,000 | +85.7% | 0.01% | +25.0% |
| Q3 2017 | $3,649,000 | – | 3,602,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |